{"schema_version":"secwatch.filing_event.v1","accession":"0001698530-24-000150","form_type":"8-K/A","ticker":"XCUR","cik":"0001698530","company_name":"EXICURE, INC.","filed_at":"2024-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.261862+00:00","generated_at":"2026-05-28T23:20:25.639385+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Exicure shareholders approve $8.7M HiTron investment; CEO and board changes; Nasdaq plan presented","bullets":["Shareholders approved $8.7M second investment from HiTron; total HiTron investment $10M at $3/share.","Upon close, HiTron becomes Exicure's largest shareholder with >50% ownership.","Board expanded to 9 directors; 4 new directors appointed; Andy Yoo named CEO effective Dec 19, 2024.","Company plans additional ~$2.4M raise targeting total ~$15M; in discussions with a US therapeutics company.","Presented Nasdaq compliance plan on Dec 17, 2024 for equity requirement; awaiting Panel decision."],"urls":{"canonical":"https://secwatch.observer/filing/0001698530-24-000150","json":"https://secwatch.observer/filing/0001698530-24-000150.json","markdown":"https://secwatch.observer/filing/0001698530-24-000150.md","text":"https://secwatch.observer/filing/0001698530-24-000150.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1698530/000169853024000150/0001698530-24-000150-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1698530/000169853024000150/xcur-20241220.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:20:25.639385+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}